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CASE REPORTS
Transesophageal echo-guided endovascular
exclusion of thoracic aortic mobile thrombi
Enrique Criado, MD,a Phillip Wall, MD,a Paul Lucas, MD,b Antonios Gasparis, MD,a Trent Proffit,
MD,b and John Ricotta, MD,a Stony Brook, NY; and Baltimore, Md
Mobile luminal thrombus of the descending thoracic aorta is an unusual finding in patients with peripheral embolization.
The diagnosis is best made with transesophageal echography (TEE). Traditionally, systemic anticoagulation and selective
surgical thrombectomy are standard treatment. We present a case report of recurrent mobile thrombus despite surgical
thrombectomy and systemic anticoagulation. We treated it with endovascular exclusion of a descending thoracic aorta
emboligenic lesion with an endoluminal stent graft, using simultaneous TEE and fluoroscopic intraoperative guidance.
The patient remains symptom-free 9 months after stent-graft implantation. TEE-guided endoluminal exclusion should
be considered in treatment of descending thoracic aorta emboligenic lesions. (J Vasc Surg 2004;39:238-42.)
Mobile intraluminal debris in the descending thoracic
aorta is an unusual, but worrisome finding in patients with
evidence of peripheral arterial embolization. The diagnosis
is usually made at transesophageal echography (TEE). The
natural history of these lesions is unclear, but they are found
mostly in patients with established episodes of emboliza-
tion. Therefore treatment is mandatory, because of poten-
tial risk for recurrent embolization. Management of tho-
racic aortic mobile thrombi includes systemic
anticoagulation, and direct surgical thrombectomy in se-
lected patients. Alternative treatments include aortic sub-
stitution, thromboendarterectomy, and iliac artery ligation
with extra-anatomic bypass grafting. To our knowledge,
transluminal exclusion of thoracic mobile thrombus is not
described in the English literature. We present a case report
of recurrent thoracic aortic mobile thrombus previously
treated with anticoagulation and surgical thrombectomy,
which was finally treated successfully with an edoluminal
stent graft.
CASE REPORT
A 60-year-old woman came to the emergency room with acute
onset of left flank pain. She had no history of urinary tract disease.
Physical examination revealed normal blood pressure and temper-
ature. The abdomen was obese, not tender, not distended, and
without palpable masses or audible bruits. The left flank was very
tender to percussion. All peripheral pulses were palpable. Sinus
rhythm was present. Medical history was remarkable only for
hypertension, hypercholesterolemia, cigarette smoking, and obe-
sity.
An initial computed tomography (CT) scan of the abdomen
revealed bilateral renal infarctions, large on the left and small on
the right, and proximal occlusion of the superior mesenteric artery
with an intraluminal thrombus (Fig 1). The abdominal aorta was
normal. Findings at transthoracic cardiac echography were within
normal limits. A chest CT scan and thoracic and abdominal angio-
grams did not demonstrate a potential source of emboli. The white
blood cell count was normal, as were findings at urinalysis. Blood
for a hypercoagulable state work-up laboratory panel was drawn,
but yielded normal values. In view of the findings the patient was
admitted to the hospital, and heparinization was performed. Re-
sults of abdominal examination remained benign; hemoglobin,
creatinine concentration, and white blood cell count were within
normal limits; and the patient tolerated a diet. For those reasons, it
was concluded that the superior mesenteric artery occlusion was
probably chronic; therefore revascularization was not considered.
To search for a possible embolic source, a TEE was obtained.
This echogram revealed a large, floating, extremely mobile mural
thrombus in the thoracic aorta, tethered to an area of intimal
irregularity located a few centimeters distal to the subclavian artery
(Fig 2). In view of the worrisome appearance of the thoracic
thrombus, the patient was taken to the operating room for direct
surgical thrombectomy. Through a left fifth intercostal space tho-
racotomy, the descending thoracic aorta was exposed. With intra-
operative ultrasonography the thrombus was localized, and the
descending thoracic aorta was clamped distally and proximally to
the thrombus. The thrombus was removed through a longitudinal
aortotomy. It was found attached by a very thin peduncle to an area
of shallow ulceration. The thrombus itself was thin, almost filmlike,
but was more than 5 cm long and 2 cm wide.
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The aorta was closed with a running suture of 3-0 monofila-
ment polypropylene. A repeat intraoperative ultrasound scan re-
vealed minor irregularities in the aortic luminal surface, but no
residual floating thrombus. A chest tube was placed. Postopera-
tively, because of uninterrupted heparin therapy, a large hemotho-
rax developed, which required repeat exploration of the chest and
evacuation of the hematoma. After this procedure, the patient did
well and on postoperative day 12 was discharged to home, with
warfarin therapy.
One month after surgery, a repeat TEE revealed a new mobile
thrombus, 5 to 10 mm in greatest diameter, located in the previous
surgical area, with persistent luminal surface irregularity extending
about 8 cm. The diameter of the ulcerated segment of aorta was 28
to 30 mm, as measured on the TEE scan. To prevent further
embolization, endoluminal exclusion of the thrombogenic ulcer-
ated thoracic aorta was planned. With intraoperative TEE, the
ulcerated area containing the mobile thrombus was located. The
proximal extent of the ulcerated aorta was visualized, and the
transesophageal probe was secured in place to mark the area.
With the patient receiving systemic heparinization, the right
common femoral artery was surgically exposed. An 8-mm-diame-
ter polytetrafluoroethylene (PTFE) graft was dilated to 30 mm
diameter by 10 cm length, and sutured proximally to a P5010
Palmaz stent with PTFE suture. The stent graft was wrapped over
a 30 mm diameter by 5-cm-long angioplasty balloon and secured
with 6-0 polypropylene ligatures. A 20F 65-cm-long Keller-Tim-
merman introducer sheath was advanced through the right femoral
artery into the descending thoracic aorta over a stiff 0.035 inch
wire. The stent graft mounted over the balloon was advanced
through the introducer sheath into the descending thoracic aorta.
With fluoroscopic guidance, the stent graft was advanced to the
level of the transesophageal probe, marking the proximal limit of
the aortic ulceration containing the mobile thrombus. The balloon
was inflated at this level under simultaneous fluoroscopic and TEE
guidance (Fig 3). A second P5010 Palmaz stent was placed in the
distal half of the PTFF graft and expanded with a 30-mm balloon,
again with simultaneous fluoroscopic and TEE guidance.
On completion of the procedure, a TEE scan showed com-
plete coverage of the ulcerated aorta and excellent apposition of
the stent graft to the aortic wall. No residual luminal thrombus was
visualized. Likewise, the completion angiogram and plain fluoro-
scopic scan revealed excellent positioning of the stent graft, with-
out luminal defects (Fig 4). No complications developed. The
patient was discharged to home 3 days later, with oral anticoagu-
lation therapy, because of the possible presence of other areas of
aortic intimal disease susceptible to further thrombus formation,
not covered by the endograft. Nine months after surgery, the
patient remains symptom-free with oral anticoagulation therapy,
with a normal creatinine concentration. A follow-up CT scan
demonstrated a well-positioned graft, and no aortic anomalies.
Fig 1. A, CT scan demonstrates superior mesenteric artery thom-
bus (long arrow) and extensive left renal infarct. B, Angiogram
shows superior mesenteric artery occlusion distal to middle colic
artery. C, Angiogram depicts vascular defect in lower pole of left
kidney.
Fig 2. Transesophageal echogram demonstrates large free-float-
ing thrombi in descending thoracic aorta in transverse (top) and
longitudinal (bottom) views.
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Fig 3. Periprocedural transverse transesophageal echogram demonstrates undeployed stent graft in center of thoracic
aortic lumen (left), and expanded stent graft apposed to aortic wall after deployment (right).
Fig 4. Left, Completion fluoroscopic scan shows two Palmaz stents contouring descending thoracic aorta, and
demonstrates how transesophageal probe can be used to guide positioning of stent graft with simultaneous use of
fluoroscopy. Right, Completion angiogram after deployment of stent graft.
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DISCUSSION
Use of TEE has greatly improved visualization of le-
sions involving the thoracic aorta. Diagnosis of mobile
mural thrombi of the nonaneurysmal thoracic aorta was
rare until the advent of this diagnostic method, and was
occasionally found at autopsy or during surgical explora-
tion. In a large autopsy series Machleder et al1 found mural
thrombus in the thoracic aorta in 0.09% of 10,671 autop-
sies, but they made no distinction between adherent and
mobile mural thrombi. Despite widespread availability of
TEE, mobile thoracic aortic thrombi are seldom found. In
2001, Choukroun et al 2 reported nine such cases diag-
nosed with TEE at a single large hospital over 6 years. Their
review of the literature revealed fewer than 120 cases re-
ported from 1993 to 2001, with an incidence of mobile
thoracic aortic thrombi in patients with peripheral emboli-
zation ranging between 0.8% and 9%, depending on the
population studied.
Although the natural history of mobile aortic thrombi
is not well known, the diagnosis is mainly confirmed during
evaluation of established peripheral embolization. This
suggests a definite risk for peripheral embolization associ-
ated with mobile aortic thrombi. In a recent report, Klocker
et al 3 suggested the association of mobile thoracic aortic
debris and blue toe syndrome. In their study, mobile tho-
racic aortic debris was associated with recurrent emboliza-
tion in 30% of patients, but carried low risk for limb loss.
However, they found a remarkably high incidence of renal
dysfunction at diagnosis, and progression to renal insuffi-
ciency over the long term. Our patient had preserved renal
function; however, recurrent renal infarction could cer-
tainly jeopardize long-term renal function. Asymptomatic
thoracic aortic mobile thrombi have been found in 0.8% of
patients with vascular disease undergoing TEE during rou-
tine intraoperative monitoring.4 It is likely that mobile
thoracic aortic thrombi occur more frequently than re-
ported in patients with symptoms, because of the limita-
tions of angiography and CT in enabling confirmation of
the diagnosis. Our case report illustrates how the diagnosis
of large mobile intraluminal aortic thrombi can be missed
with conventional angiography and CT. Although mag-
netic resonance imaging may be more sensitive for detec-
tion of thoracic aortic thrombi, it is associated with a
significant risk for false positive diagnosis.2 It appears un-
disputable that TEE is currently the most reliable method
for detection of mobile aortic thrombi in the thoracic aorta.
Pathologic correlation of TEE and operative specimens
confirmed that mobile aortic debris was formed by throm-
bus in a small group of patients with associated complex
thoracic aortic plaques.5
Management of mobile thoracic aortic thrombi is not
well established. Choukroun et al2 initially used hepariniza-
tion in four patients with cerebral or peripheral emboliza-
tion, followed by long-term oral anticoagulation therapy,
without recurrence of symptoms at 1 to 6 years of follow-
up. In contrast, Rossi et al6 found 12 patients with emboli
from the descending thoracic aorta who had received oral
anticoagulation therapy, and found recurrent emboli in 4
patients, whereas among 10 patients treated surgically there
was one perioperative death but no recurrence of emboli
during follow-up. Patients with persistent or enlarging
thrombi or recurrent emboli despite anticoagulation ther-
apy have undergone surgical thrombectomy with excellent
initial results, but recurrent emboli developed in two of six
surgically treated patients described in the literature.2,7
In the present case, immediate surgical thrombectomy
was performed because the mobile thrombus was deemed a
serious embolic threat. Early recurrence of mobile thrombi,
despite oral anticoagulation therapy, prompted the need
for further treatment. Recurrent thrombus development
was likely related to residual aortic wall irregularity. Perhaps
the use of oral anticoagulation with coumadin is not opti-
mal in this situation, and a strong antiplatelet regimen may
be better. The impressive visualization of the aortic lesion
with TEE compelled us to proceed with TEE-guided en-
doluminal exclusion. Embolizing lesions of the infrarenal
aorta and peripheral arteries have been successfully treated
with endoluminal stent grafting.8 We therefore expanded
the indication to the treatment of thoracic aortic lesion.
TEE facilitates implantation of thoracic aortic endolumi-
nal prostheses for treatment of aneurysm and dissection.9,10
Furthermore, it has been suggested that TEE actually is supe-
rior to angiography in enabling detection of thoracic en-
doleak.11 In our experience, TEE has been invaluable for
accurate placement of stent grafts that perhaps would have
been impossible to place safely without TEE.
In conclusion, mobile thoracic aortic thrombus may not
be exhibited on conventional angiograms or CT scans, but is
well visualized with TEE. Early recurrence of intraluminal
thrombi after surgical thrombectomy and oral anticoagulation
therapy is possible, and can be treated with TEE-guided
endoluminal stent-graft implantation. Consideration should
be given to TEE-guided endoluminal exclusion of mobile
thoracic aortic thrombi as initial treatment.
Special thanks to Mr Jonathan Cohen for editorial
assistance.
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